Morbidity and Mortality Weekly Report: MMWRU.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 2008 |
From inside the book
Results 1-5 of 56
Page 333
... ( ACIP ) for Use of 7 - Valent Pneumococcal Conjugate Vaccine ( PCV7 ) in Children Aged 24-59 Months Who Are Not Completely Vaccinated 344 Notices to Readers 346 QuickStats 334 The MMWR series of publications is published by the.
... ( ACIP ) for Use of 7 - Valent Pneumococcal Conjugate Vaccine ( PCV7 ) in Children Aged 24-59 Months Who Are Not Completely Vaccinated 344 Notices to Readers 346 QuickStats 334 The MMWR series of publications is published by the.
Page 343
In February 2000 , PCV7 , marketed as Prevnar® and manufactured by Wyeth Vaccines ( Collegeville , Pennsylvania ) ... is recommended for children aged ≤23 months , using fewer doses depending on age at the time of first vaccination .
In February 2000 , PCV7 , marketed as Prevnar® and manufactured by Wyeth Vaccines ( Collegeville , Pennsylvania ) ... is recommended for children aged ≤23 months , using fewer doses depending on age at the time of first vaccination .
Page 344
ACIP's rationale for limiting the recommendation for routine vaccination to children aged 24-59 months who have certain ... The ACIP Pneumococcal Vaccines Work Group reviewed data on safety and immunogenicity of PCV7 in children aged ...
ACIP's rationale for limiting the recommendation for routine vaccination to children aged 24-59 months who have certain ... The ACIP Pneumococcal Vaccines Work Group reviewed data on safety and immunogenicity of PCV7 in children aged ...
Page 393
... the efficacy of vaccination with These findings demonstrate that , in any season , assessment activated influenza ... effectiveness of influenza vaccines cannot be zically confirmed influenza infection has been estimated determined ...
... the efficacy of vaccination with These findings demonstrate that , in any season , assessment activated influenza ... effectiveness of influenza vaccines cannot be zically confirmed influenza infection has been estimated determined ...
Page 393
15 - During clinical trials , the efficacy of vaccination with activated influenza vaccines for the prevention of sero- gically confirmed influenza infection has been estimated high as 70 % -90 % among healthier adults .
15 - During clinical trials , the efficacy of vaccination with activated influenza vaccines for the prevention of sero- gically confirmed influenza infection has been estimated high as 70 % -90 % among healthier adults .
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
Common terms and phrases
2008 are provisional 52 weeks activity acute Additional aged American associated Atlantic California caused Central clinical Columbia Continued Control Cumulative year-to-date counts Current week Dakota data for reporting deaths Department of Health detection Disease Surveillance System District Electronic England estimates exposure fatalities fever Health and Human Hepatitis HIV/AIDS hospital identified Incidence increased infants infection influenza Islands Jersey June laboratory levels Mariana Maximum measles Median Mexico Michigan MMWR months mortality National Center North occurred outbreak patients pediatric percentage persons population positive practices Prevention Previous Previous 52 weeks providers public health received recommended reported reporting years 2007 Rico risk samples season selected notifiable diseases serogroup South symptoms Table testing tion United vaccination viral Virginia virus viruses Washington week Med Max weekly weeks ending West Western blot workers York City ZZZZ